K. Peony Yu

Chief Medical Officer at FibroGen, Inc.

K. Peony Yu

K. Peony Yu

Chief Medical Officer at FibroGen, Inc.

Biography

K. Peony Yu, M.D.

Chief Medical Officer

Dr. Yu, Chief Medical Officer, joined FibroGen in 2008. Dr. Yu oversees all global and regional clinical development strategies and execution of the various clinical programs, as well as providing leadership for the roxadustat program. She brings more than 25 years of pharmaceutical leadership, patient care, and drug development experience with deep expertise in all aspects of clinical and regulatory process, and with multiple prior successful NDA/MAAs for novel drugs and drug/device combos. Prior to joining FibroGen, Dr. Yu served as Vice President of Clinical Research at Anesiva Inc. Previously, Dr. Yu was Director of Clinical Development at ALZA Corporation (now Johnson & Johnson); Director of Clinical Development at Pain Therapeutics Inc.; and Assistant Director, Clinical Development, at Elan Corporation plc (now Perrigo Company plc). Earlier in her career, Dr. Yu was Head of the Department of Physical Medicine & Rehabilitation at the Palo Alto Medical Foundation. Dr. Yu received a B.S. in Chemical Engineering from University of California, Davis, and an M.D. from the UC Davis School of Medicine. She completed her residency training at Stanford University School of Medicine. Dr. Yu is a native of China.

Overview
RelSci Relationships

611

Number of Boards

1

Birthday

1963

Age

58

Relationships
RelSci Relationships are individuals K. Peony Yu likely has professional access to. A relationship does not necessarily indicate a personal connection.

Interim President at FibroGen, Inc.

Relationship likelihood: Strong

Chief Executive Officer at FibroGen, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at STAAR Surgical Co.

Relationship likelihood: Strong

Vice President-Clinical Development at FibroGen, Inc.

Relationship likelihood: Strong

Counsel at Goodwin Procter LLP

Relationship likelihood: Strong

Executive Director, Clinical Development at FibroGen, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Chief Accounting Officer at FibroGen, Inc.

Relationship likelihood: Strong

Chief Intellectual Property Officer at FibroGen, Inc.

Relationship likelihood: Strong

Chief Business Officer at FibroGen, Inc.

Relationship likelihood: Strong

Chief Legal Officer at FibroGen, Inc.

Relationship likelihood: Strong

Paths to K. Peony Yu
Potential Connections via
Relationship Science
You
K. Peony Yu
Chief Medical Officer at FibroGen, Inc.
Career History
Chief Medical Officer
Current

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

Other Affiliations

K. Peony Yu is affiliated with FibroGen, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by K. Peony Yu. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of K. Peony Yu's profile does not indicate a business or promotional relationship of any kind between RelSci and K. Peony Yu.